In addition, a set of core signaling pathways, like PI3K, ERK1/2, NFkB, JAK-STAT, p38MAPK, JNK, were activated, which are the potential therapeutic targets, like JAK2, for identifying potentially effective COVID-19 treatments. This evidence concerns the gene MAPK3 and COVID-19.